Genitourinary tuberculosis: a study of short course regimens

Journal of Urology

Volumn 115, Issue 6, 1976, Pages 707-711

  Gow, J G ^a  

^a Liverpool Reg Urol Cent Liverpool ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

DIAGNOSIS; DRUG THERAPY; MAJOR CLINICAL STUDY; THERAPY; URINARY TRACT DISEASE; UROGENITAL TUBERCULOSIS;

EID: 0017195199     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)59342-8     Document Type: Article

References (21)

1. Fox W. The John Barnwell lecture: changing concepts in the chemotherapy of pulmonary tuberculosis Amer. Rev. Resp. Dis. 97 1968 767
2. Gyselen A. Verbist L. Cosemans J. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis Acta Tuberc. Belg. 60 1969 563
3. Newman R. Doster B. Murray F.J. Ferebee S. Rifampin in initial treatment of pulmonary tuberculosis Amer. Rev. Resp. Dis. 103 1971 461
4. Nitti V. Catena E. Veneri F.D. De Michele G. Marra A. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis Amer. Rev. Resp. Dis. 103 1971 329
5. Dormer B.A. Salinger P.L. A comparative trial with combinations of rifampicin, ethambutol and isoniazid (hydron-san) in previously untreated cases of pulmonary tuberculosis S. Afr. Med. J. 45 1971 697
6. Dickinson J.M. Mitchison D.A. Suitability of rifampicin for intermittent administration in the treatment of tuberculosis Tubercle 51 1970 82
7. Aquinas M. Allan W.G.L. Horsfall P.A.L. Jenkins P.K. Hung-Yan W. Girling D. Tall R. Fox W. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong Brit. Med. J. 1 1972 765
8. Lees A.W. Allan G.W. Smith J. Tyrrell W.F. Fallon R.J. Toxicity from rifampicin plus isoniazid and rifampicin plus ethambutol therapy Tubercle 52 1971 182
9. Campese V.M. Marzullo F. Schena F.P. Coratelli P. Acute renal failure during intermittent rifampicin therapy Nephron 10 1973 256
10. Worlledge S. Rifampicin and current policies in antituberculous chemotherapy D.M. Burley Ciba Foundation Symposium 1972 Little, Brown and Co. Boston 87
11. Lirzin M. Le: Rifampicin and current policies in antituberculous chemotherapy D.M. Burley Ciba Foundation Symposium 1972 Little, Brown and Co. Boston 94
12. Lirzin, M. Le: Personal communication, 1975.
13. Second East African/British Research Council Study: Controlled clinical trial of four short-course (6-month) regimes of chemotherapy for treatment of pulmonary tuberculosis Lancet 2 1974 1100
14. Campbell I.A. BTTA optimum duration of chemotherapy study Tubercle suppl. 4 1974 8
15. Acocella, G.: International Congress of Chemotherapy, Vienna, June 26–July 1, suppl. 1, p. 87, 1967.
16. Kurth K.H. Sulmoni A. Die konservative Behandlung der Urogenitaltuberkulose Ther. Umsch. 29 1972 232
17. May P. Clinical findings with rifampicin in tuberculosis of the urogenital tract Antibiot. Chemother. 16 1970 480
18. Pines A. Raafat H. Siddiqui G.M. Rifampicin and ethambutol in the treatment of drug resistant and for advanced pulmonary tuberculosis (with a note on capreomycin) J. Irish Med. Ass. 63 1970 82
19. Lattimer J.K. Wechsler H. Ehrlich R.M. Fukushima K. Current treatment for renal tuberculosis J. Urol. 102 1969 2
20. Gow J.G. Results of treatment in a large series of cases of genitourinary tuberculosis and the changing pattern of the disease Brit. J. Urol. 42 1970 647
21. Pearce S.J. Horne N.W. Followup of patients with pulmonary tuberculosis adequately treated by chemotherapy: is this really necessary? Lancet 2 1974 641